Navigation Links
PDL BioPharma Elects Barry Selick to Its Board of Directors
Date:8/3/2009

INCLINE VILLAGE, Nev., Aug. 3 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced the appointment of Harold E. ("Barry") Selick, Ph.D., to the Company's Board of Directors.

"Barry's experience as a seasoned biotechnology executive and his extensive knowledge of PDL's humanization technology will allow him to make valuable contributions to our strategy and operations as we seek to maximize the value of our antibody humanization patents and related assets and monetize these assets for our stockholders," said John McLaughlin, president and chief executive officer of PDL.

Dr. Selick has served as chief executive officer of Threshold Pharmaceuticals since June 2002. From January 1999 to April 2002, he was chief executive officer of biotechnology company Camitro Corporation. From 1992 to 1999, he worked at Affymax Research Institute, the drug discovery technology development center for Glaxo Wellcome plc, most recently as vice president of Research. Prior to joining Affymax, he held scientific positions at Protein Design Labs, Inc. and Anergen, Inc. As a staff scientist at Protein Design Labs, he was a co-inventor of the technology underlying the creation of fully humanized antibody therapeutics and applied this technology to PDL's first product, Zenapax (R), which was developed and commercialized by Roche for the prevention of kidney transplant rejection. Dr. Selick received his B.S. and Ph.D. from the University of Pennsylvania and was a Damon Runyon-Walter Winchell Cancer Fund Fellow and an American Cancer Society Senior Fellow at the University of California, San Francisco.

About PDL BioPharma, Inc.

PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatme
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
2. PDL BioPharma Announces Second Quarter 2009 Financial Results
3. PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009
4. DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller
5. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
6. Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
7. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
8. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
9. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
10. PDL BioPharma Announces Record Date for October 1 Dividend Payment
11. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Okyanos, the leader in ... The study was conducted to determine the emotional impact ... and sports-related injuries have had on those affected. ... most prevalent symptom reported at 73%, followed by 66% ... and bending over. Over half of respondents, 56%, said ...
(Date:5/5/2015)... 05, 2015 On April 8th, 2015, ... CA, Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, ... producer of sustainable product placement in TV and film. ... top providers of ecologically sound and socially conscious products ... carpet event that makes appearances at various awards ceremonies ...
(Date:5/5/2015)... Don’t have time to go to the ... Don’t know which workout equipment to use? LiveStreamingFitness.com ... help members achieve their heath and fitness goals and ... caused-based wellness company, today announces the launch of LiveStreamingFitness.com, ... by certified trainers, nutritional information and recipes provided by ...
(Date:5/5/2015)... 2015 Major League Ultimate (MLU) was ... that ultimate Frisbee™ is home to many amazing athletes, ... engages the world. Nike Ultimate Camps’ goal of spreading ... for young athletes to learn about the sport and ... perfect fit. , The Nike Ultimate Camp in Philadelphia ...
(Date:5/5/2015)... May 05, 2015 Igantia , ... Francisco, leads an international initiative to examine key biological ... the human lifespan. Scientists at Igantia believe that ... from the initiation of her menstrual cycle to her ... for aging and, ultimately, extend the lifespan. , ...
Breaking Medicine News(10 mins):Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2
... to other parts of the body could improve understanding ... stroke. Scientists at the University of Edinburgh have ... function of the segment of nerve fibres that controls ... published in the journal Neuron , could help ...
... time however some women experience overwhelming ,baby blues, before the ... result in premature birth, or low birth weight, and impact ... research published in BioMed Central,s open access journal BMC ... husband or partner is the strongest predictor of maternal emotional ...
... SUNDAY, March 13 (HealthDay News) -- With spring allergy ... controlling their allergies, says the American College of Allergy, ... , Over-the-counter (OTC) oral antihistamines are less effective than ... may control some allergy symptoms but have little effect ...
... , FRIDAY, March 11 (HealthDay News) -- People would prefer ... especially if they know others are watching, says a new ... likely to think badly of them if they do something ... to the research in the journal Psychological Science . ...
... 11 (HealthDay News) -- Text messages may help smokers kick ... according to researchers who conducted two studies on 27 heavy ... pinpoint the brain regions most active in controlling urges to ... a series of momentary self-control skirmishes." The study found that ...
... fluids bathing the brain are essential for building the ... in the journal Neuron . The finding promises ... stem cells., Before now, the fluid surrounding the brain ... that simply maintained the brain,s ionic balance. Recent reports ...
Cached Medicine News:Health News:When Someone Is Watching, You're Less Inclined to Do Bad Things 2Health News:Text Messages May Help Smokers Kick the Addiction, Small Study Finds 2Health News:Stem cells take cues from fluid in the brain 2Health News:Stem cells take cues from fluid in the brain 3
(Date:5/5/2015)... , May 5, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... announced today that Clint Severson , chairman and chief ... Lynch 2015 Health Care Conference on Tuesday, May 12, 2015 ... the Encore at the Wynn in Las Vegas, ... worldwide developer, manufacturer and marketer of portable blood analysis systems ...
(Date:5/5/2015)... Mass., May 5, 2015   Cynosure, Inc. ... medical devices for aesthetic procedures and precision surgical applications ... ended March 31, 2015. First-Quarter Highlights: ... , Non-GAAP earnings of $0.15 per share; GAAP ... million at March 31, 2015 "Cynosure delivered ...
(Date:5/5/2015)... , May 5, 2015  Stryker Orthopaedics announced ... Ponte Vedra, FL.  Since becoming the ... Champions Tour" over one year ago, the company has ... Tour combined, with its onsite activation the Stryker Mobility ... on the importance of joint health. Proving to be ...
Breaking Medicine Technology:Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 2Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 3Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 5Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 6Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 7Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 8Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 9Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 10Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 11Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 3
... Germany, September 1 Biosensors,International Group, Ltd ... a next-generation drug-eluting stent,developed by Biosensors, has ... Johnson & Johnson,s industry leading drug-eluting stent, ... angiographic,follow-up data. The results of the landmark ...
... against placebo, in reducing the ... stroke and hospitalization for congestive heart failure ... current standard of care, RIDGEFIELD, Conn., ... the,TRANSCEND(TM)* trial demonstrated that treatment with MICARDIS(R),(telmisartan) ...
Cached Medicine Technology:Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 3TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 2TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 3TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 4TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 5TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 6TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet 7
Information on diagnosis and management of 500 common or important medical and surgical disorders....
The workhorse electric system....
... BD Safety Knife with BD Xstar Blade ... that protects the blade in prodedure and ... based on a grind-less process for manufacturing ... outstanding sharpness and consistency. The arch ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
Medicine Products: